


iovera°
Medical Equipment Manufacturing • Brisbane, California, United States • 21-50 Employees
Company overview
| Headquarters | Brisbane, California, United States |
| Phone number | +18004420989 |
| Websites | |
| SIC | 283 |
| Keywords | Anesthesia, Pain Management, Orthopedics, Non-Opioid, Osteoarthritis, Total Knee Arthroplasty, Chronic Knee Pain |
| Employees | 21-50 |
| Socials |
Key Contacts at iovera°
Dana Myers
Regional Operations Director
Erin Tiernan
Director, Human Resources
Bob Curtis
Ceo
Donna Wilson
Director Of Field Clinical Education
Erin Tiernan
Director Of Hr
iovera° Email Formats
iovera° uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@myoscience.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@myoscience.com | 100% |
About iovera°
This page is intended for US audiences. At Pacira Biosciences, Inc., we are driving innovation to provide ways to manage pain safely and effectively. iovera° is a patented, 510(k)-cleared medical device, which uses targeted cryoanalgesia for immediate and long-lasting pain relief. iovera° treats peripheral nerves to temporarily stop pain signals for up to 90 days and provides pain relief until the nerve regenerates and nerve signaling is restored through an innovative handheld design. The iovera° system is used to destroy tissue during surgical procedures by applying freezing cold. It can also be used to produce lesions in peripheral nervous tissue by the application of cold to the selected site for the blocking of pain. It is also indicated for the relief of pain and symptoms associated with osteoarthritis of the knee for up to 90 days. The iovera° system is not indicated for treatment of central nervous system tissue. iovera° should not be used for people with: cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud’s disease, open and/or infected wounds at or near treatment site. Patients treated with iovera° (a needle-based therapy) may have certain reactions, including but not limited to bruising, swelling, inflammation and/or redness, local pain and/or tenderness, altered feeling at application site. Proper iovera° use (see User Guide) can help reduce or prevent these reactions: in treatment area(s) – skin damage from being exposed to cold/heat, skin darkening/lightening, skin dimples; outside treatment area(s) – muscles may not work/move normally. Adverse event reporting: email drugsafety@pacira.com or call 1-855-793-9727. Product quality complaints: email drugsafety@pacira.com or call 1-800-442-0989. Please don't report such information through this or other social media pages owned by Pacira Biosciences, Inc. If you do report through this page, Pacira reserves the right to contact you for information.
iovera° revenue & valuation
| Annual revenue | $15,000,000 |
| Revenue per employee | $625,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $48,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
iovera° has 10 employees across 6 departments.
Departments
Number of employees
Funding Data
iovera° has never raised funding before.
iovera° Tech Stack
Discover the technologies and tools that power iovera°'s digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Tag managers
Hosting
Reverse proxies
JavaScript libraries
Programming languages
Analytics
JavaScript libraries
UI frameworks
JavaScript libraries
Analytics
Frequently asked questions
4.8
40,000 users



